Prospective Single Arm CAS - ROADSAVER Study
Launched by TERUMO EUROPE N.V. · Apr 19, 2018
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
1. Baseline Assessments
The patient will be assessed in accordance with the hospital standard of care for patients treated with carotid artery stenting procedure, which in general includes:
* Informed consent for data collection
* Demographics
* Medical History
* Medication record
* Physical examination
* Carotid Duplex Ultrasound
* Neurological Assessment
* Diffusion weighted Magnetic Resonance Imaging (DW-MRI)
* Procedural angiography
Baseline assessments will be performed prior to the index procedure and documented in the patient medical record. Baselin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient has a non-occlusive and non-thrombotic carotid artery stenosis and is eligible to be treated with Roadsaver Carotid Stent as per the Instructions for Use (IFU)
- • The patient is at least 18 years of age
- • The patient has a life expectancy of at least 12 months from the date of the index procedure
- • The patient is able and willing to provide a signed IRB-/EC-approved informed consent form prior to participation
- Exclusion Criteria:
- • - Any condition that makes patient unsuitable for percutaneous transluminal angioplasty (PTA), including intolerance or allergy to any material used and accompanying therapy
About Terumo Europe N.V.
Terumo Europe N.V. is a leading global medical technology company dedicated to advancing healthcare through innovative solutions. With a strong focus on the development and manufacturing of a wide range of medical devices, including vascular intervention, surgical, and blood management products, Terumo Europe N.V. is committed to enhancing patient outcomes and improving the efficiency of healthcare delivery. The organization adheres to rigorous clinical trial standards and regulatory compliance, ensuring that its products meet the highest quality and safety benchmarks. By fostering collaboration with healthcare professionals and leveraging cutting-edge research, Terumo Europe N.V. aims to contribute significantly to the evolution of medical practices and patient care across Europe and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Leuven, , Belgium
Barcelona, , Spain
Belgrade, , Serbia
Tenerife, , Spain
Passau, , Germany
Bonheiden, , Belgium
Novi Sad, , Serbia
Pécs, , Hungary
Kortrijk, , Belgium
Toledo, , Spain
Dendermonde, , Belgium
Suhl, , Germany
Groningen, , Netherlands
Aalst, , Belgium
Budapest, , Hungary
Szeged, , Hungary
A Coruña, , Spain
Jaén, , Spain
Barcelona, , Spain
San Sebastián, , Spain
Grenoble, , France
Riga, , Latvia
Skopje, , North Macedonia
Skopje, , North Macedonia
Oldenburg, , Germany
Palma De Mallorca, , Spain
Münster, , Germany
Ostrava, , Czechia
Bratislava, , Slovakia
Mannheim, , Germany
Prague, , Czechia
Bayonne, , France
Marseille, , France
Nancy, , France
Berlin, , Germany
Berlin, , Germany
Bruchsal, , Germany
Flensburg, , Germany
Frankfurt/Main, , Germany
Karlsbad, , Germany
Radebeul, , Germany
Ulm, , Germany
Budapest, , Hungary
Kaposvár, , Hungary
Kecskemét, , Hungary
Székesfehérvár, , Hungary
Nieuwegein, , Netherlands
Bydgoszcz, , Poland
Kraków, , Poland
Kraków, , Poland
Vila Nova De Gaia, , Portugal
Belgrad, , Serbia
Nitra, , Slovakia
Girona, , Spain
Marbella, , Spain
Valladolid, , Spain
Patients applied
Trial Officials
Ihsen Merioua, MD
Study Director
Ihsen.Merioua@terumo-europe.com
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials